UNBRIDLE YOUR POTENTIAL
RESTORING POTENTIAL
Important Safety Information: PRASCEND is for use in horses only. Treatment with
PRASCEND may cause loss of appetite. Most cases are mild. Weight loss, lack of energy
and behavioral changes also may be observed. If severe, a temporary dose reduction may
be necessary. PRASCEND has not been evaluated in breeding, pregnant or lactating horses,
and may interfere with reproductive hormones in these horses. PRASCEND Tablets
should not be crushed due to the potential for increased human exposure.
Refer to package insert for complete product information.
THE HORSE YOU KNOW IS STILL IN THERE.
You and your horse have a unique connection, a bond like no other. But the clinical signs of PPID (pituitary pars
intermedia dysfunction) can make a horse unrecognizable. Their energy, their vibrant coat, their overall spark can fade
and disappear as the disease sets in and progresses. Here's the good news: The horse you know is still in there, hiding
behind the signs of PPID. What's even better? Prascend
®
(pergolide tablets), the fi rst and only FDA approved-treatment
for PPID, can control the signs associated with PPID, and bring back the horse you know. Learn more at Prascend.com
Prascend is a registered trademark of Boehringer Ingelheim Vetmedica, Inc.
©2017 Boehringer Ingelheim Vetmedica, Inc. EQU-0199-PRAS0717